# Passage BIO, Inc.: Form 8-K, filed May 26, 2023

- Company: [Passage BIO, Inc.](/companies/pasg.md) (CIK 1787297)
- Form: 8-K
- Filed: 2023-05-26
- Accepted by EDGAR: May 26, 2023, 16:27 ET
- Period: 2023-05-25
- Accession: 0001104659-23-065493
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1787297/000110465923065493/tm2317140d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1787297/000110465923065493/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1787297/000110465923065493/tm2317140d1_8k.htm

Filed May 26, 2023.
Source: SEC EDGAR, the filing index for accession 0001104659-23-065493. Last ingested by Listed: Nov 10, 2026, 16:52 ET. No prices; not investment advice.
